Improvement in Renal Function in High Immunologic Risk Kidney Transplant Recipients Switched From Tacrolimus to Belatacept

被引：1
|
作者：
Gupta, G. [1 ]
Kumar, D. [1 ]
Cotterell, A. [1 ]
Sharma, A. [1 ]
Posner, M. [1 ]
Ren, Q. [1 ]
Posner, S. [1 ]
King, A. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01520
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A203
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [31] Patient and Graft Outcome Among High Immunologic Risk Renal Transplant Recipients
    Mora, Jeffrey
    Cabanayan-Casasola, Concesa B.
    Padua, Florecita R.
    Mendoza, Myrna T.
    TRANSPLANTATION, 2018, 102 : S90 - S91
  • [32] Belatacept in Chronic Kidney Disease Stabilizes and Improves Renal Function in Pancreas Transplant Recipients: Intermediate Results
    Chen, J.
    Mujtaba, M.
    Taber, T.
    Yaqub, M.
    Powelson, J.
    Adebiyi, O.
    Fridell, J.
    Sharfuddin, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 352 - 352
  • [33] BELATACEPT VERSUS TACROLIMUS: RESULTS OF AN INDIRECT ANALYSIS FROM A SYSTEMATIC REVIEW OF IMMUNOSUPPRESSIVE THERAPIES FOR KIDNEY TRANSPLANT RECIPIENTS
    Sidhu, M.
    Odeyemi, A. O.
    Hart, W. M.
    Dada, B. R.
    VALUE IN HEALTH, 2011, 14 (07) : A330 - A330
  • [34] Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients
    Lo, A
    Egidi, MF
    Gaber, LW
    Gaber, AO
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 105S - 108S
  • [35] CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept
    Karadkhele, Geeta
    Hogan, Julien
    Magua, Wairimu
    Zhang, Weiwen
    Badell, Idelberto Raul
    Mehta, Aneesh
    Lyon, Marshall
    Pastan, Stephen
    Pearson, Thomas C.
    Larsen, Christian P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (01) : 208 - 221
  • [36] Belatacept Vs. Tacrolimus: Clinical Outcomes in De Novo Kidney Transplant Recipients.
    Wongsaroj, P.
    Kahwaji, J.
    Vo, A.
    Choi, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 457 - 457
  • [37] Outcomes in Kidney Transplant Recipients with Pretransplant Uncontrolled Diabetes on Belatacept versus Tacrolimus Based Immunosuppression
    Durham, R.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S993 - S993
  • [38] Renal Transplantation in Immunologic High Risk Recipients
    Salas, P.
    Pinto, V.
    Zambrano, P.
    Grandy, J.
    Corta, B.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1897 - 1897
  • [39] Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction
    Snyder, Heather S.
    Duhart, Benjamin T., Jr.
    Krauss, Amy G.
    Rao, Vinaya
    SAGE OPEN MEDICAL CASE REPORTS, 2016, 4
  • [40] Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease
    Lee, Wei-Chen
    Wu, Tsung-Han
    Wang, Yu-Chao
    Cheng, Chih-Hsien
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Ching-Song
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
12345